Former Attorney General Pam Bondi received a thyroid cancer diagnosis shortly after President Donald Trump removed her from the nation's top law enforcement post, BBC News reported, citing CBS News. The 60-year-old has already undergone surgery and continues treatment while preparing to testify before the House Oversight Committee over her handling of the Epstein files.
Bondi left the Department of Justice at the beginning of April. The diagnosis came soon after. The cancer's stage has not been disclosed, but thyroid cancer carries a five-year survival rate above 98 percent, according to the Cleveland Clinic.
Despite the diagnosis, Bondi has not stepped away from public life. She has been tapped to serve on the Presidential Council of Advisors on Science and Technology, the White House advisory body on artificial intelligence that Trump established by executive order in January 2025, and she is scheduled to appear before House lawmakers on Friday.
Katie Miller, a podcast host and former White House adviser, disclosed Bondi's condition on social media. Miller wrote that Bondi "has been quietly kicking cancer's a** the last few weeks" and added that Bondi "has a heart of gold." The post brought into public view a health battle Bondi had apparently kept private during weeks of treatment and recovery.
Vice President JD Vance issued a statement affirming Bondi's continued role in the administration's orbit. Newsmax reported Vance's remarks:
"Pam has been an enormously valuable asset to the president's team, and I'm thrilled for her and for all of us that she's going to remain involved in confronting some of the most important issues the administration faces."
Trump himself praised Bondi's tenure at the Justice Department. Fox News reported that the president posted on Truth Social: "Pam did a tremendous job overseeing a massive crackdown in Crime across our Country, with Murders plummeting to their lowest level since 1900. We love Pam."
When she departed DOJ, Bondi struck a gracious tone. She told reporters she was "excited to be entering a role in the private sector." The New York Post reported that Bondi also said she remained "eternally grateful for the trust that President Trump placed in me to Make America Safe Again." The specific private-sector position she planned to take has not been named publicly.
Bondi's appointment to PCAST places her alongside some of the most prominent names in American technology. The council's first members, announced in March 2026, include Google co-founder Sergey Brin, Meta CEO Mark Zuckerberg, Oracle co-founder Larry Ellison, and Nvidia CEO Jensen Huang.
Trump's executive order creating the council described its mission as an effort to "unite the brightest minds from academia, industry, and government to guide our Nation through this critical moment by charting a path forward for American leadership in science and technology." Bondi's legal background adds a different dimension to a panel dominated by Silicon Valley heavyweights.
The appointment also keeps Bondi inside the administration's advisory circle at a moment when the White House has seen significant turnover. Bondi is the fourth cabinet-level official to leave her post this year. Former Homeland Security Secretary Kristi Noem and former Labor Secretary Lori Chavez-DeRemer were also removed from their positions.
Last week, Tulsi Gabbard stepped down as director of national intelligence after her husband received a bone cancer diagnosis, a sobering parallel to Bondi's own situation and a reminder that personal crises do not pause for political calendars.
Bondi's health news arrives against the backdrop of a politically charged congressional inquiry. The House Oversight Committee has subpoenaed Bondi over the DOJ's release of files related to Jeffrey Epstein. She is scheduled to testify Friday.
The Epstein file release drew bipartisan criticism. Democratic lawmakers argued that important files were withheld from the public. Both Bondi and Trump faced questions about the scope and completeness of the disclosure. Specific details about which files were allegedly held back have not been made public in the available reporting.
That Bondi intends to appear before the committee while undergoing cancer treatment says something about her willingness to face scrutiny head-on. Whether lawmakers on either side of the aisle will adjust their tone in light of her diagnosis remains to be seen. Congressional hearings rarely make room for compassion once the cameras turn on.
The broader political landscape around the Trump administration continues to shift rapidly. Internal pressures on the president's legislative agenda have added complexity to an already turbulent period, and the string of high-profile departures from the cabinet only sharpens the challenge of maintaining policy momentum.
Several key questions remain unanswered. The White House has not publicly stated why Trump removed Bondi from the attorney general post. The exact date of her cancer diagnosis has not been disclosed. Nor has anyone specified the stage of her thyroid cancer, though the Cleveland Clinic's survival statistics suggest the prognosis is favorable regardless of stage.
The administration's handling of the transition, removing Bondi from DOJ but quickly folding her into PCAST, suggests an effort to keep a loyal and experienced figure close. Vance's public statement reinforced that message. Whatever led to her departure from the Justice Department, the White House appears to view Bondi as someone worth retaining in an advisory capacity.
Threats against figures in the Trump orbit have not been limited to political pressure. Recent security concerns involving the president's family underscore that serving this administration carries risks well beyond the ordinary burdens of public office.
Bondi's decision to keep working through a cancer diagnosis, accepting a new advisory role, preparing for congressional testimony, and staying engaged in public life, reflects a seriousness that Washington could use more of. She did not retreat. She did not leak her diagnosis for sympathy. She showed up.
The political class will spend Friday grilling her about Epstein files. Fair enough. Oversight matters. But the facts of the past few weeks tell their own story: a 60-year-old woman received a cancer diagnosis, had surgery, and kept working, all while the people who fired her publicly praised her and the people who oppose her sharpened their subpoenas.
Washington measures loyalty in press releases and power in committee gavels. Bondi, for the moment, is measuring something harder.
